Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease
Karolinska Inst, Div Translat Alzheimer Neurobiol, Ctr Alzheimer Res, Dept NVS, S-14157 Stockholm, Sweden..
Karolinska Inst, Div Translat Alzheimer Neurobiol, Ctr Alzheimer Res, Dept NVS, S-14157 Stockholm, Sweden..
Karolinska Inst, Div Translat Alzheimer Neurobiol, Ctr Alzheimer Res, Dept NVS, S-14157 Stockholm, Sweden.;Univ Manchester, Wolfson Mol Imaging Ctr, Manchester M20 3LJ, Lancs, England..
Karolinska Inst, Div Translat Alzheimer Neurobiol, Ctr Alzheimer Res, Dept NVS, S-14157 Stockholm, Sweden.;Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.;Karolinska Univ Hosp Huddinge, Dept Geriatr Med, S-14186 Stockholm, Sweden..
Show others and affiliations
2016 (English)In: Brain, ISSN 0006-8950, E-ISSN 1460-2156, Vol. 139, no 3, 922-936 p.Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

The relationships between pathophysiological processes in Alzheimer's disease remain largely unclear. In a longitudinal, multitracer PET study, Rodriguez-Vieitez et al. reveal that progression of autosomal dominant Alzheimer's disease is accompanied by prominent early and then declining astrocytosis, increasing amyloid plaque deposition and decreasing glucose metabolism. Astrocyte activation may initiate Alzheimer pathology.See Schott and Fox (doi: 10.1093/brain/awv405) for a scientific commentary on this article. The relationships between pathophysiological processes in Alzheimer's disease remain largely unclear. In a longitudinal, multitracer PET study, Rodriguez-Vieitez et al. reveal that progression of autosomal dominant Alzheimer's disease is accompanied by prominent early and then declining astrocytosis, increasing amyloid plaque deposition and decreasing glucose metabolism. Astrocyte activation may initiate Alzheimer pathology.Alzheimer's disease is a multifactorial dementia disorder characterized by early amyloid-beta, tau deposition, glial activation and neurodegeneration, where the interrelationships between the different pathophysiological events are not yet well characterized. In this study, longitudinal multitracer positron emission tomography imaging of individuals with autosomal dominant or sporadic Alzheimer's disease was used to quantify the changes in regional distribution of brain astrocytosis (tracer C-11-deuterium-L-deprenyl), fibrillar amyloid-beta plaque deposition (C-11-Pittsburgh compound B), and glucose metabolism (F-18-fluorodeoxyglucose) from early presymptomatic stages over an extended period to clinical symptoms. The 52 baseline participants comprised autosomal dominant Alzheimer's disease mutation carriers (n = 11; 49.6 +/- 10.3 years old) and non-carriers (n = 16; 51.1 +/- 14.2 years old; 10 male), and patients with sporadic mild cognitive impairment (n = 17; 61.9 +/- 6.4 years old; nine male) and sporadic Alzheimer's disease (n = 8; 63.0 +/- 6.5 years old; five male); for confidentiality reasons, the gender of mutation carriers is not revealed. The autosomal dominant Alzheimer's disease participants belonged to families with known mutations in either presenilin 1 (PSEN1) or amyloid precursor protein (APPswe or APParc) genes. Sporadic mild cognitive impairment patients were further divided into C-11-Pittsburgh compound B-positive (n = 13; 62.0 +/- 6.4; seven male) and C-11-Pittsburgh compound B-negative (n = 4; 61.8 +/- 7.5 years old; two male) groups using a neocortical standardized uptake value ratio cut-off value of 1.41, which was calculated with respect to the cerebellar grey matter. All baseline participants underwent multitracer positron emission tomography scans, cerebrospinal fluid biomarker analysis and neuropsychological assessment. Twenty-six of the participants underwent clinical and imaging follow-up examinations after 2.8 +/- 0.6 years. By using linear mixed-effects models, fibrillar amyloid-beta plaque deposition was first observed in the striatum of presymptomatic autosomal dominant Alzheimer's disease carriers from 17 years before expected symptom onset; at about the same time, astrocytosis was significantly elevated and then steadily declined. Diverging from the astrocytosis pattern, amyloid-beta plaque deposition increased with disease progression. Glucose metabolism steadily declined from 10 years after initial amyloid-beta plaque deposition. Patients with sporadic mild cognitive impairment who were C-11-Pittsburgh compound B-positive at baseline showed increasing amyloid-beta plaque deposition and decreasing glucose metabolism but, in contrast to autosomal dominant Alzheimer's disease carriers, there was no significant longitudinal decline in astrocytosis over time. The prominent initially high and then declining astrocytosis in autosomal dominant Alzheimer's disease carriers, contrasting with the increasing amyloid-beta plaque load during disease progression, suggests astrocyte activation is implicated in the early stages of Alzheimer's disease pathology.

Place, publisher, year, edition, pages
2016. Vol. 139, no 3, 922-936 p.
Keyword [en]
astrocytosis, autosomal dominant Alzheimer's disease, C-11-deuterium-L-deprenyl, F-18-fluorodeoxyglucose, C-11-Pittsburgh compound B
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-282820DOI: 10.1093/brain/awv404ISI: 000371694600031PubMedID: 26813969OAI: oai:DiVA.org:uu-282820DiVA: diva2:917597
Funder
Swedish Research Council, 05817Swedish Foundation for Strategic Research Knut and Alice Wallenberg FoundationStockholm County CouncilThe Swedish Brain FoundationThe Dementia Association - The National Association for the Rights of the DementedEU, European Research CouncilStiftelsen Gamla TjänarinnorWenner-Gren Foundations
Available from: 2016-04-07 Created: 2016-04-07 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

fulltext(1075 kB)187 downloads
File information
File name FULLTEXT01.pdfFile size 1075 kBChecksum SHA-512
7fbfdb686229d7e6f2a2e5f85e0765ccc3fd146a1e789186b5cb915226d6d372aa78f2c14326ed7252b32a117f98d6d56e56598b1d9a3ac4e5193d7574fa742d
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wall, AndersLångstrom, Bengt
By organisation
RadiologyDepartment of Chemistry - BMC
In the same journal
Brain
Neurology

Search outside of DiVA

GoogleGoogle Scholar
Total: 187 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 509 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf